🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study

Recruitingn/aAges 18 Years - anyAllIstituto Ortopedico Rizzoli
NCT06189079 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To date, arterial embolization constitutes one of the most popular methods in minimally invasive treatment of bone metastases, allowing good results in terms of pain reduction, local control of disease and reduction of peri-operative bleeding, with low invasiveness.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients of either sex of age or older who are candidates for embolization therapy * Life expectancy \> 3 months * Single metastatic or oligometastatic. * Plurimetastatic if a particular site is causing painful symptoms or at risk for pathologic rupture Exclusion Criteria: * Patients with life expectancy \<3 months or severe functional status impairment (ASA 4) * Patients with hypovascular metastasis documented by angiography or MRI perfusion study with MDC. * Patients with coagulation deficiency or plateletopenic patients. * Patients with documented active infection.
💊

What it tests

  • Not listed
📍

Where

1 site
Istituto Ortopedico Rizzoli
Bologna, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy